ICTR Announces 10th Round of ATIP Recipients

The ICTR is pleased to announce the recipients of the tenth round of Accelerated Translational Incubator Pilot (ATIP) Program awards. These awards are designed to provide starter funds for innovative work that specifically focuses on translating laboratory and/or clinical research into the ability to better prevent, treat, or manage disease. By using ATIP funding to support these clinical and translational studies in their earliest phases, the ICTR plans to promote the development of new drugs, devices, and diagnostics that will directly improve patient care.  The following investigators were awarded up to $100,000 each.


Biswal, Shyam Preclinical lead candidate selection for “first in class NRF2 inhibitors” as anti-cancer drug for lung cancer
Golub, Jonathan COach2Quit: a novel mHealth application for smoking cessation
Habashi, Jennifer Does Routine Administration of Pitocin to Postpartum Women Increase the Risk of Aortic Dissection in Marfan Syndrome
Katz, Howard Real Time Neurological Biomarker Assay Applicable to Rapid Brain Injury Indication
Le Thi, Quy  Hoa (Anne) Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy
Lin, Frank Providing Hearing Health Care to Patients at the Johns Hopkins Memory Clinic
Robertson,  Courtney Targeting Arachidonic Acid Metabolites to Improve Outcome after Pediatric Traumatic Brain Injury
Rojas, Camilo Inhibition of neutral sphingomyelinase 2 for the protection of remyelination in multiple sclerosis
Semba, Richard Development and validation of a new assay for the accurate determination of vitamin D status
Weiss, Cliff Inside-out sterilization of central lines

 

Any faculty member at Johns Hopkins University interested in starting a translational project is eligible to apply for ATIP funding; junior faculty are particularly encouraged and will receive extra consideration. The continuance and renewal of funding is dependent upon the achievement of specific, timeline-related milestones.